Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06503341

A Hospital-Based Registry of Preventive Cardiology Clinics

Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention

Status
Recruiting
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
National Institute of Cardiovascular Diseases, Pakistan · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

More research is needed to articulate the most effective ways to use these tools as screening tests in cardiovascular risk assessments and how they ultimately affect CVD mortality and morbidity outcomes. Clinicians are encouraged to continue sharing decision-making with patients to combine their unique cardiovascular risk factors and develop a comprehensive, effective treatment plan.

Detailed description

Study Design: observational study Duration of Study: ongoing. Sample Size: All patients presenting to preventive cardiology clinics at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.. Sampling Technique: Non-probability consecutive sampling Data Collection Procedure: Verbal informed consent will be obtained from all the patients regarding their participation in the study and publication of study findings while maintaining confidentiality. Consecutive patients presenting preventive cardiology clinics at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan, will be included in this registry. Demographic characteristics, physical examination, clinical history, risk modification, lab assessment, and ASCVD risk score at presentation and at every follow-up will be recorded using a structural questionnaire. Data Analysis Procedure: The Tentative analysis plan uses collected data for research publications. The statistical package for social sciences (SPSS 21) will be used to analyze baseline characteristics. The Shapiro-Wilk test will be applied to check the hypothesis of normality for quantitative (continuous) variables. Descriptive statistics such as mean ± SD, median (IQR), skewness, maximum, and minimum will be calculated for quantitative (continuous) variables. Frequency and percentages will be calculated for categorical variables.

Conditions

Interventions

TypeNameDescription
OTHERCardiovascular risk assesmentASCVD Score and WHO Cardiovascular Risk score.

Timeline

Start date
2021-06-17
Primary completion
2031-06-01
Completion
2041-06-01
First posted
2024-07-16
Last updated
2026-04-13

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06503341. Inclusion in this directory is not an endorsement.